--- title: Red Queen Bio is using AI to design antibodies for... description: Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million total to use AI for designing antibody drugs against viruses, including future... canonical: https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Red Queen Bio is using AI to design antibodies for future viruses, WSJ says | daily.dev og:description: Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million total to use AI for designing antibody drugs against viruses, including future... og:url: https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll og:image: https://api.daily.dev/og/posts/pP83lZSLL.png og:image:alt: Red Queen Bio is using AI to design antibodies for future viruses, WSJ says og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Red Queen Bio is using AI to design antibodies for future viruses, WSJ says **[The Next Web](https://daily.dev/sources/tnw)** · 2 min read · 2 upvotes · 0 comments ## Summary Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million total to use AI for designing antibody drugs against viruses, including future threats that AI systems could help create. The company starts with bird flu and influenza antibodies, planning first clinical trials in 2027, before expanding to coronaviruses, Ebola-like viruses and smallpox relatives. Its design-test-repeat loop uses AI to design antibodies, lab-tests them in cells, and feeds results back into the models. Founded by Nikolai Eroshenko and Hannu Rajaniemi after spinning out of HelixNano in 2025, OpenAI led its $15 million seed round last November alongside Cerberus Ventures, Fifty Years and Halcyon Futures. The company states it avoids gain-of-function research and never handles dangerous pathogens directly, positioning itself alongside other AI biosecurity efforts like Google DeepMind's program and Anthropic's push for a UN ban on AI bioweapons. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: ## Questions this post answers ### What is Red Queen Bio and what does it do with AI? Red Queen Bio is a biosecurity startup that uses AI to design antibody drugs against viruses, starting with bird flu and other influenza strains. It grows cells to produce and lab-test candidate antibodies, then feeds results back into its AI models to iterate toward tighter-binding, more scalable antibodies. Founded by Nikolai Eroshenko and Hannu Rajaniemi after spinning out of HelixNano in 2025, it has raised $36 million total, with OpenAI leading its $15 million seed round. _Developers tracking how AI labs move into biosecurity can follow this space on daily.dev._ ### Which company led Red Queen Bio's seed funding round and how much was raised? OpenAI led Red Queen Bio's $15 million seed round, announced in November, alongside Cerberus Ventures, Fifty Years and Halcyon Futures. The company has since raised $36 million in total funding to build AI-designed antibody drugs against viruses, including bird flu, with plans to target coronaviruses, Ebola-like viruses and smallpox relatives after starting clinical trials in 2027. _Anyone following AI investment trends in biotech can track funding news like this via daily.dev._ ## Similar posts on daily.dev - [The specter of AI-enabled bioweapons is a wake-up call for biotech](https://daily.dev/posts/the-specter-of-ai-enabled-bioweapons-is-a-wake-up-call-for-biotech-vm1ybkvw4) · MIT Technology Review · 0 upvotes · 0 comments - [Co-Scientist](https://daily.dev/posts/co-scientist-eih1hhppo) · DeepMind · 0 upvotes · 0 comments - [Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz](https://daily.dev/posts/converge-bio-raises-25m-backed-by-bessemer-and-execs-from-meta-openai-wiz-tjjncwirh) · TechCrunch · 0 upvotes · 0 comments --- Tags: [#startup](https://daily.dev/tags/startup), [#openai](https://daily.dev/tags/openai) [View this post on daily.dev](https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Red Queen Bio is using AI to design antibodies for future viruses, WSJ says","url":"https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll"},"datePublished":"2026-09-28T17:51:57.725Z","dateModified":"2026-09-28T17:52:17.122Z","description":"Red Queen Bio, a biosecurity startup backed by OpenAI, has raised $36 million total to use AI for designing antibody drugs against viruses, including future...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/30af0c5908c77db89f1e7950ab194489?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/30af0c5908c77db89f1e7950ab194489?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"The Next Web","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"The Next Web","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/tnw","url":"https://daily.dev/sources/tnw"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":2},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"startup,openai","timeRequired":"PT2M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"The Next Web","item":"https://daily.dev/sources/tnw"},{"@type":"ListItem","position":3,"name":"Red Queen Bio is using AI to design antibodies for future viruses, WSJ says"}]} {"@context":"https://schema.org","@type":"FAQPage","@id":"https://daily.dev/posts/red-queen-bio-is-using-ai-to-design-antibodies-for-future-viruses-wsj-says-pp83lzsll#faq","mainEntity":[{"@type":"Question","name":"What is Red Queen Bio and what does it do with AI?","acceptedAnswer":{"@type":"Answer","text":"Red Queen Bio is a biosecurity startup that uses AI to design antibody drugs against viruses, starting with bird flu and other influenza strains. It grows cells to produce and lab-test candidate antibodies, then feeds results back into its AI models to iterate toward tighter-binding, more scalable antibodies. Founded by Nikolai Eroshenko and Hannu Rajaniemi after spinning out of HelixNano in 2025, it has raised $36 million total, with OpenAI leading its $15 million seed round. Developers tracking how AI labs move into biosecurity can follow this space on daily.dev."}},{"@type":"Question","name":"Which company led Red Queen Bio's seed funding round and how much was raised?","acceptedAnswer":{"@type":"Answer","text":"OpenAI led Red Queen Bio's $15 million seed round, announced in November, alongside Cerberus Ventures, Fifty Years and Halcyon Futures. The company has since raised $36 million in total funding to build AI-designed antibody drugs against viruses, including bird flu, with plans to target coronaviruses, Ebola-like viruses and smallpox relatives after starting clinical trials in 2027. Anyone following AI investment trends in biotech can track funding news like this via daily.dev."}}]} ```